Cecilie R.
- Country
- Denmark
- Department
- N/A
Research Overview
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- J3L-MC-EZEB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults with Elevated Lipoprotein(a)
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
Data & Insights
Has run more than one trial at 628 of 1162 partner sites.
Specializations
Cardiovascular Research
This investigator specializes in atherosclerotic cardiovascular disease (ASCVD) management and prevention, with particular focus on reducing major adverse cardiovascular events. Their research extends to lipoprotein disorders and innovative therapeutic approaches for cardiovascular risk reduction.
- Coronary heart disease interventions
- Primary ASCVD prevention
- Lipid management strategies
Musculoskeletal Medicine
The investigator conducts extensive research in osteoarthritis treatment, particularly focusing on knee conditions and chronic pain management. Their work includes studies on rotator cuff tendinopathy and innovative approaches to cartilage regeneration.
- Knee osteoarthritis therapies
- Shoulder conditions
- Chronic pain management
Specialty Areas
Their research portfolio includes studies in polymyalgia rheumatica, early Alzheimer's disease, and metabolic conditions including type 2 diabetes and obesity. This work demonstrates expertise in complex therapeutic areas requiring specialized intervention approaches.
- Rheumatic conditions
- Neurodegenerative disorders
- Metabolic diseases
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.